We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+26.62%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$928M
AUM Growth
+$345M
Cap. Flow
+$252M
Cap. Flow %
27.11%
Top 10 Hldgs %
11.09%
Holding
2,007
New
1,014
Increased
209
Reduced
154
Closed
611

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Healthcare 10.9%
3 Consumer Discretionary 8.92%
4 Financials 6.54%
5 Industrials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARAY icon
1226
Accuray
ARAY
$35.6M
$51K 0.01%
+12,247
New +$44.9K
SMMT icon
1227
Summit Therapeutics
SMMT
$11.8B
$51K 0.01%
+10,835
New +$45.9K
STKS icon
1228
The ONE Group
STKS
$56.5M
$51K 0.01%
13,710
-9,925
-42% -$28.1K
AUVI
1229
DELISTED
Applied UV, Inc. Common Stock
AUVI
$51K 0.01%
90
-4
-4% -$2.9K
NXE icon
1230
NexGen Energy
NXE
$7.03B
$50K 0.01%
+18,112
New +$36.3K
SINT icon
1231
SiNtx Technologies
SINT
$11.6M
$50K 0.01%
2
FSR.WS
1232
DELISTED
Fisker Inc. Warrants, each whole warrant exercisable for one Class A common stock at an exercise pri
FSR.WS
$50K 0.01%
+10,240
New +$48.4K
SXC icon
1233
SunCoke Energy
SXC
$788M
$49K 0.01%
+11,279
New +$47.2K
PCPL.WS
1234
DELISTED
CC Neuberger Principal Holdings I Warrants, each whole warrant exercisable for one Class A ordinary
PCPL.WS
$49K 0.01%
+21,052
New +$36.2K
BMY.RT
1235
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$49K 0.01%
+70,627
New +$150K
CBIO
1236
Crescent Biopharma
CBIO
$624M
$48K 0.01%
+128
New +$44.9K
KRKR
1237
36Kr Holdings
KRKR
$6M
$48K 0.01%
+855
New +$50.4K
PVLA
1238
Palvella Therapeutics
PVLA
$2.24B
$48K 0.01%
+239
New +$49.7K
AGRX
1239
DELISTED
Agile Therapeutics
AGRX
$48K 0.01%
8
-30
-79% -$177K
COCP icon
1240
Cocrystal Pharma
COCP
$15.3M
$47K 0.01%
2,866
-4,774
-62% -$66.3K
EVOK
1241
DELISTED
Evoke Pharma
EVOK
$47K 0.01%
+127
New +$65.5K
ONCY
1242
Oncolytics Biotech
ONCY
$96.1M
$47K 0.01%
+19,587
New +$46.9K
STSA
1243
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$47K 0.01%
10,133
-28,929
-74% -$125K
LGHL
1244
Lion Group Holding
LGHL
$717K
0
ENVB icon
1245
Enveric Biosciences
ENVB
$6.12M
$45K ﹤0.01%
+1
New +$52.5K
VATE icon
1246
INNOVATE Corp
VATE
$103M
$45K ﹤0.01%
+1,385
New +$38.5K
LEJU
1247
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$45K ﹤0.01%
+1,977
New +$46.5K
NNA
1248
DELISTED
Navios Maritime Acquisition Corporation
NNA
$45K ﹤0.01%
14,414
-14,953
-51% -$57.7K
NBACR
1249
DELISTED
Newborn Acquisition Corp. Right
NBACR
$45K ﹤0.01%
+32,718
New +$26.7K
GOVX icon
1250
GeoVax Labs
GOVX
$4.27M
$44K ﹤0.01%
+35
New +$40.7K

Similar funds

Virtu Financial's Q4 2020 Portfolio in Review

As of Q4 2020, Virtu Financial held 2,007 positions worth $928M, up 59% from $583M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtu Financial deployed $252M of net new capital in Q4 2020, opening 1,014 new positions and adding to 209 existing holdings. Its largest new stake was Burgundy Technology Acquisition Corporation Unit: 1,113,379 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $42.9M trimmed.

  • Virtu Financial's largest Q4 2020 buy was Burgundy Technology Acquisition Corporation Unit: 1,113,379 shares worth $12.6M.
  • Virtu Financial added most to Vanguard S&P 500 ETF in Q4 2020, an estimated $12.1M increase.
  • Virtu Financial's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $42.9M.
  • Virtu Financial fully exited abrdn Physical Silver Shares ETF in Q4 2020, selling an estimated $12.2M.
  • Virtu Financial's ten largest holdings make up 11% of its $928M portfolio in Q4 2020.
  • Virtu Financial opened 1,014 new positions and closed 611 in Q4 2020.
  • Virtu Financial's portfolio value rose 59% quarter-over-quarter to $928M.

Based on Virtu Financial's 13F filing for Q4 2020, filed 24 Feb 2021.